
Sign up to save your podcasts
Or


Our co-hosts discuss the currently active & accruing NRG-GI008 study, also known as the "CIRCULATE-NORTH AMERICA" study. This study will evaluate what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.
By NRG Oncology5
1010 ratings
Our co-hosts discuss the currently active & accruing NRG-GI008 study, also known as the "CIRCULATE-NORTH AMERICA" study. This study will evaluate what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.

30,649 Listeners

43,765 Listeners

112,617 Listeners

56,472 Listeners

9,505 Listeners

6,445 Listeners

61 Listeners

3,000 Listeners

5,518 Listeners

9,909 Listeners

16,081 Listeners

10,892 Listeners

2,287 Listeners

189 Listeners

37 Listeners